Perfil
Kent Taylor is Senior Vice President-Sales at Palvella Therapeutics, Inc. since 2026.
Formerly, Mr. Taylor was Director-Dermatology Atopic Dermatitis at Onset Dermatologics LLC, Head-Sales & Marketing at Encore Dermatology, Inc., and Vice President-Sales at Arcutis Biotherapeutics, Inc. in 2023.
Mr. Taylor completed undergraduate education at the University of Arizona.
Cargos activos de Kent Taylor
| Empresas | Cargo | Inicio |
|---|
Antiguos cargos conocidos de Kent Taylor.
| Empresas | Cargo | Fin |
|---|---|---|
Onset Dermatologics LLC
Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription products for skin health | Corporate Officer/Principal | - |
Encore Dermatology, Inc.
Encore Dermatology, Inc. Medical SpecialtiesHealth Technology Operates as a dermatology company, manufactures prescription therapies and medical devices for dermatologists | Ventas & Marketing | - |
| ARCUTIS BIOTHERAPEUTICS, INC. | Ventas & Marketing | - |
Formación de Kent Taylor.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onset Dermatologics LLC
Onset Dermatologics LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription products for skin health | Health Technology |
Encore Dermatology, Inc.
Encore Dermatology, Inc. Medical SpecialtiesHealth Technology Operates as a dermatology company, manufactures prescription therapies and medical devices for dermatologists | Health Technology |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
- Bolsa de valores
- Insiders
- Kent Taylor
















